[Back]
Dipl.-Ing. Dr. Winfried Neuhaus, Privatdoz.
T: +43-1-4277-55085
http://homepage.univie.ac.at/winfried.neuhaus/
Huber A, Sarne V, Beribisky AV, Ackerbauer D, Derdak S, Madritsch S et al. Generation and characterization of a human neuronal in vitro model for Rett Syndrome using a direct reprogramming method. Stem cells and development. 2024 Mar 1;33(5-6):128-142. Epub 2024 Jan 2. doi: 10.1089/scd.2023.0233
Spreitzer I, Keife J, Strasser T, Kalaba P, Lubec J, Neuhaus W et al. Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution. International Journal of Molecular Sciences. 2023 Dec;24(23):16956. doi: 10.3390/ijms242316956
Kristofova M, Aher YD, Ilic M, Radoman B, Kalaba P, Dragacevic V et al. A daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval. Behavioural Brain Research. 2018 May 2;343:83-94. doi: 10.1016/j.bbr.2018.01.032
Saroja SR, Aher YD, Kalaba P, Aher NY, Zehl M, Korz V et al. A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3. Behavioural Brain Research. 2016 Oct 1;312:127-137. doi: 10.1016/j.bbr.2016.06.011
Thal SC, Neuhaus W. The Blood-Brain Barrier as a Target in Traumatic Brain Injury Treatment. Archives of Medical Research. 2014 Nov;45(8):698-710. doi: 10.1016/j.arcmed.2014.11.006
Neuhaus W, Gaiser F, Mahringer A, Franz J, Riethmueller C, Foerster C. The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Frontiers in Cellular Neuroscience. 2014 Oct 28;8:352. doi: 10.3389/fncel.2014.00352
Bruno RR, Neuhaus W, Roewer N, Wunder C, Schick MA. Molecular Size and Origin Do Not Influence the Harmful Side Effects of Hydroxyethyl Starch on Human Proximal Tubule Cells (HK-2) In Vitro. Anesthesia and Analgesia. 2014 Sep;119(3):570-577. doi: 10.1213/ANE.0000000000000325
Novakova I, Subileau E-A, Toegel S, Gruber D, Lachmann B, Urban E et al. Transport Rankings of Non-Steroidal Antiinflammatory Drugs across Blood-Brain Barrier In Vitro Models. PLoS ONE. 2014 Jan 23;9(1):e86806. e86806. doi: 10.1371/journal.pone.0086806
Neuhaus W, Burek M, Djuzenova CS, Thal SC, Koepsell H, Roewer N et al. Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells. Neuroscience Letters. 2012;506(1):44-49. doi: 10.1016/j.neulet.2011.10.045
Shityakov S, Neuhaus W, Dandekar T, Förster C. Analyzing Molecular Polar Surface Descriptors to Predict Blood-Brain Barrier Permeation. Journal of Neuroimmune Pharmacology. 2012;7(Suppl. 1):55-55.
Neuhaus W, Mandikova J, Linz B, Bennani-Baiti B, Lachmann B, Noe C. Blood-brain barrier in vitro models as tools in drug discovery: Assessment of the transport ranking of antihistaminic drugs. Die Pharmazie: an international journal of pharmaceutical sciences. 2012;67(5):432-439. doi: 10.1691/ph.2012.1742
Neuhaus W, Samwer F, Kunzmann S, Muellenbach R, Wirth M, Speer CP et al. Lung endothelial cells strengthen, but brain endothelial cells weaken barrier properties of a human alveolar epithelium cell culture model. Differentiation: ontogeny, neoplasia and differentiation therapy. 2012;84(4):294-304. doi: 10.1016/j.diff.2012.08.006
Neuhaus W, Schick MA, Bruno RR, Schneiker B, Förster C, Roewer N et al. The Effects of Colloid Solutions on Renal Proximal Tubular Cells In Vitro. Anesthesia and Analgesia. 2012;114(2):371-374.
Neuhaus W, Freidl M, Szkokan P, Berger ML, Wirth M, Winkler J et al. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model. Brain Research. 2011;1394:49-61. doi: 10.1016/j.brainres.2011.04.003
Neuhaus W, Stessl M, Strizsik E, Bennani-Baiti B, Wirth M, Winkler J et al. Blood-Brain Barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein. Neuroscience Letters. 2010;469(2):224-228. doi: 10.1016/j.neulet.2009.11.079
Plattner V, Germann B, Neuhaus W, Noe C, Gabor F, Wirth M. Characterization of two blood-brain barrier mimicking cell lines: distribution of lecitin binding sites and perspectives for drug delivery. International Journal of Pharmaceutics. 2010;387(1-2):34-41. doi: 10.1016/j.ijpharm.2009.11.030
Pötsch V, Bennani-Baiti B, Neuhaus W, Muchitsch EM, Noe C. Serum-derived Immunoglobulins alter Amyloid-ß transport across a blood brain barrier in vitro model. Die Pharmazie: an international journal of pharmaceutical sciences. 2010;65(4):267-273. doi: 10.1691/ph.2010.9319
Pötsch V, Neuhaus W, Noe C. Serum-Derived Immunoglobulins Neutralize Adverse Effects of Amyloid-beta Peptide on the Integrity of a Blood-Brain Barrier In Vitro Model. Journal of Alzheimer's Disease. 2010;21(1):303-314. doi: 10.3233/JAD-2010-090769
Noe C, Neuhaus W, Germann B, Plattner V, Gabor F, Wirth M. Alteration of the glycocalyx of two blood-brain mimicking cell lines is inducible by glioma conditioned media. Brain Research. 2009;82-89.
Ecker G, Chiba P, Neuhaus W, Noe C. Transport at the Blood-Brain Barrier. In Ecker G, Chiba P, editors, Transporters as Drug Carriers. Structure, Function, Substrates. Wiley. 2009. p. 263-298. (Methods and Principles in Medicinal Chemistry). doi: 10.1002/9783527627424.ch10

Microfluidic system to study the impact of flow on particle-cell interactions

Winfried Neuhaus (Contributor)

20 Nov 2009

Activity: Talks and presentations › Talk or oral contribution › Other

Evaluation of a Blood-Brain Barrier in vitro Model Based on Primary Rat Cells

Winfried Neuhaus (Speaker)

16 Apr 2009

Activity: Talks and presentations › Talk or oral contribution › Other

APTS-labeled dextrans: A new tool for characterizing cell layer's tightness

Winfried Neuhaus (Speaker)

4 Nov 2006

Activity: Talks and presentations › Talk or oral contribution › Other

Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien

T: +43-1-4277-55085

winfried.neuhaus@univie.ac.at